Use of adrenomedullin as a therapeutic agent for the treatment of excessive angiogenesis
Details for Australian Patent Application No. 2008303893 (hide)
International Classifications
Event Publications
22 April 2010 PCT application entered the National Phase
PCT publication WO2009/040029 Priority application(s): WO2009/040029
20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008303896-Use of a peptide as a therapeutic agent
2008303889-Use of neuropeptide SF, alone or in combination with GLP-2, as a therapeutic agent
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser